Life Spine announced 1Q18 ProLift® expandable spacer revenue growth of +93% vs. 1Q17.
The Micro-Invasive titanium device for TLIF and PLIF procedures supports in situ expansion to restore anatomic disc height and decompress neural elements.
ProLift was cleared for U.S. marketing in 1Q16. Limited launch followed in the next quarter, and by the end of 2017, revenue from the device grew +493% vs. the previous year.
Life Spine announced 1Q18 ProLift® expandable spacer revenue growth of +93% vs. 1Q17.
The Micro-Invasive titanium device for TLIF and PLIF procedures supports in situ expansion to restore anatomic disc height and decompress neural elements.
ProLift was cleared for U.S. marketing in 1Q16. Limited launch followed in the next quarter, and...
Life Spine announced 1Q18 ProLift® expandable spacer revenue growth of +93% vs. 1Q17.
The Micro-Invasive titanium device for TLIF and PLIF procedures supports in situ expansion to restore anatomic disc height and decompress neural elements.
ProLift was cleared for U.S. marketing in 1Q16. Limited launch followed in the next quarter, and by the end of 2017, revenue from the device grew +493% vs. the previous year.
Copy to clipboard 
